GlucoTrack Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

GCTK$1.39-32.2%Stored close · as of Oct 29, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(in thousands of US dollars except share data)

	In thousands of US dollars (except stock data)
	March 31, 2024	December 31, 2023
Unaudited
Current Assets
Cash and cash equivalents	1,497	4,492
Other current assets	440	376
Total current assets	1,937	4,868
Operating lease right-of-use asset, net (Note 3C)	77	-
Property and equipment, net	82	27
Restricted cash	10	10
TOTAL ASSETS	2,106	4,905
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable	1,014	839
Operating lease liability, current (Note 3C)	24	-
Other current liabilities	444	673
Total current liabilities	1,482	1,512
Non-current Liabilities
Loans from stockholders	195	196
Operating lease liability, non-current (Note 3C)	53	-
Total liabilities	1,730	1,708
Commitments and contingent liabilities (Note 4)	-	-
Stockholders’ Equity
Common Stock of $ 0.001 par value (“Common Stock”):
500,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 26,756,369 and 20,892,193 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	27	20
Additional paid-in capital	113,029	112,966
Receipts on account of shares	78	48
Accumulated other comprehensive income	22	16
Accumulated deficit	(112,780)	(109,853)
Total stockholders’ equity	376	3,197
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	2,106	4,905

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.